Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Notes Payables: 2010

Historic Notes Payables for OptimizeRx (OPRX) over the last 1 years, with Q4 2010 value amounting to $1.0 million.

  • OptimizeRx's Notes Payables changed N/A to $1.0 million in Q4 2010 from the same period last year, while for Dec 2010 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2010, which is N/A changed from last year.
  • As of Q4 2010, OptimizeRx's Notes Payables stood at $1.0 million.
  • OptimizeRx's 5-year Notes Payables high stood at $1.0 million for Q4 2010, and its period low was $1.0 million during Q4 2010.